← Back to Patent Explorer
US4874764A Expired / Lapsed US ⏱️ 0.0 years remaining

Benzoheterocyclic compounds

Assignee: Otsuka Pharmaceutical Co Ltd
•
Filing: 1987-06-18
•
Granted: 1989-10-17
•
Expires: 2007-06-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel 4-oxoquinoline-3-carboxylic acid compounds of the formula: ##STR1## wherein R 3 is C 1 -C 6 alkyl and R F is C 1 -C 6 alkyl, and a pharmaceutically acceptable salts thereof, said compounds having excellent antimicrobial activity and hence being useful as an antimicrobial agent, and a pharmaceutical composition containing said compound as an active ingredient.

Inventors

  • 👤 Hiraki Ueda
  • 👤 Hisashi Miyamoto
  • 👤 Shinji Aki
  • 👤 Tatsuya Otsuka

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 08:33
CPC Classifications
C; C07; C07D; C07D215/00; C07D215/02; C07D215/16; C07D215/48; C07D215/54; C07D215/56; C07D401/00; C07D401/02; C07D401/04; C07D405/00; C07D405/02; C07D405/12; C07D487/00; C07D487/02; C07D487/04

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 30 words
A compound of the formula: ##STR32## wherein R 3 is C 1 -C 6 alkyl and R F is C 1 -C 6 alkyl, or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 30 words
A compound of the formula: ##STR32## wherein R 3 is C 1 -C 6 alkyl and R F is C 1 -C 6 alkyl, or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 17 words
The compound according to claim 1, wherein R 3 is methyl, or a pharmaceutically acceptable salt thereof.
Claim 4
Dependent Claim 22 words
The compound according to claim 1, wherein R 3 is methyl, and R F is methyl, or a pharmaceutically acceptable salt thereof.
Claim 5
Dependent Claim 53 words
An antimicrobial composition which comprises as an essential active ingredient an effective amount of a compound of the formula: ##STR33## wherein R 3 is C 1 -C 6 alkyl and R F is C 1 -C 6 alkyl, or a pharmaceutically acceptable salts thereof in admixture with a pharmaceutically acceptable diluent or carrier.
Claim 6
Dependent Claim 53 words
An antimicrobial composition which comprises as an essential active ingredient an effective amount of a compound of the formula: ##STR33## wherein R 3 is C 1 -C 6 alkyl and R F is C 1 -C 6 alkyl, or a pharmaceutically acceptable salts thereof in admixture with a pharmaceutically acceptable diluent or carrier.
Claim 7
Dependent Claim 17 words
The composition according to claim 4, wherein R 3 is methyl, or a pharmaceutically acceptable salt thereof.
Claim 8
Dependent Claim 19 words
The composition according to claim 4, wherein the active compound is 7-(3-methyl-1-piperazinyl)-1-cyclopropyl-6-fluoro-8-methyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, or a pharmaceutically acceptable salt thereof.
Claim 9
Dependent Claim 28 words
A method for the treatment of bacterial infectious diseases, which comprising administering an effective amount of the compound as set forth in claim 1 as an antimicrobial agent.
Claim 10
Dependent Claim 17 words
The method according to claim 7, wherein the active compound is as set forth in claim 2.
Claim 11
Dependent Claim 19 words
The method according to claim 7, wherein the active compound is 7-(3-methyl-1-piperazinyl)-1-cyclopropyl-6-fluoro-8-methyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid, or a pharmaceutically acceptable salt thereof.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-10-16 1993-04-17 1993-10-17 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-10-16 1997-04-17 1997-10-17 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-10-16 2001-04-17 2001-10-17 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag